NRX PHARMACEUTICALS INC (NRXP) Stock Analyst Ratings
NASDAQ:NRXP - Nasdaq - US6294442099 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to NRXP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 32.3. This target is 1037.33% above the current price.
NRXP was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about NRXP.
In the previous month the buy percentage consensus was at a similar level.
NRXP was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-28 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-06 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-02 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-31 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-02 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-11-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-10-30 | EF Hutton | Maintains | Buy -> Buy |
| 2024-10-21 | EF Hutton | Initiate | Buy |
| 2024-09-12 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-08-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-07 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2023-05-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-02-02 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-09 | Ascendiant Capital | Initiate | Buy |
| 2022-06-30 | HC Wainwright & Co. | Initiate | Buy |